To join this case, fill out the form below
One Medical Investigation
By clicking on the Submit button below, I acknowledge that I have read the Retainer Agreement and agree to retain WeissLaw LLP to file an action against the Company in connection with this matter. WeissLaw LLP will prosecute the action on a contingent fee basis and will advance all costs and expenses.
By clicking on the Submit button below, I acknowledge that I have read the Derivative Retention Letter and agree to retain WeissLaw LLP to file an action against the Company in connection with this matter. WeissLaw LLP will prosecute the action on a contingent fee basis and will advance all costs and expenses.
A signed Retainer Agreement will be sent to your email shortly.
Oops! Something went wrong while submitting the form.

One Medical Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of One Medical (“One Medical” or the “Company”) (NASDAQ:ONEM) in connection with the proposed acquisition of the Company by Amazon.com, Inc. (NASDAQ: AMZN).  Under the terms of the merger agreement, the Company’s shareholders will receive $18.00 in cash for each share of One Medical common stock owned. The transaction is valued at approximately $3.9 billion.

Weiss Law is investigating whether (i) One Medical’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the $18.00 per-share merger consideration adequately compensates One Medical’s shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.

Other Cases

February 5, 2024

Everbridge, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Everbridge, Inc. (“Everbridge” or the “Company”)(NASDAQ: EVBG), in connection with its acquisition by Thoma Bravo. Under the merger agreement, the Company’s shareholders will receive $28.60 per share. The transaction is valued at approximately $1.5 billion.

Join Case →

February 5, 2024

Haynes International, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Haynes International, Inc. (“Haynes” or the “Company”) (NASDAQ: HAYN), in connection with its acquisition by North American Stainless. Under the merger agreement, the Company’s shareholders will receive $61.00 per share. The transaction is valued at approximately $970 million.

Join Case →

February 5, 2024

Catalent, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Catalent, Inc. (“Catalent” or the “Company”) (NYSE: CTLT), in connection with its acquisition by Novo Holdings. Under the merger agreement, the Company’s shareholders will receive $63.50 per share. The transaction is valued at approximately $16.5 billion.

Join Case →

Where to find us?

new york

305 Broadway, 7th FI
New York, NY 10007
(212) 682-3025

california

8383 Wilshire Blvd., Suite 935
Beverly Hills, CA 90211
(310) 208-2800

georgia

476 Hardendorf Ave. NE
Atlanta, GA 30307
(404) 692-7910

NEW JERSEY

4 Brighton Rd, Suite. 204
Clifton, NJ 07012

Copyright 2022 Weiss Law. All rights reserved

Attorney AdvertisingLegal

Design by Cramdyn